| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 151.029 | 365.128 | 565.580 | 633.118 | 565.271 | 527.159 | 546.734 | -1.191 | 828 | 0 |
| Total Income - EUR | 151.031 | 365.130 | 565.580 | 633.118 | 565.271 | 527.594 | 546.734 | -1.191 | 828 | 0 |
| Total Expenses - EUR | 137.223 | 327.684 | 516.702 | 523.736 | 468.640 | 478.275 | 375.621 | 47.078 | 757 | 0 |
| Gross Profit/Loss - EUR | 13.807 | 37.447 | 48.878 | 109.382 | 96.631 | 49.319 | 171.113 | -48.269 | 70 | 0 |
| Net Profit/Loss - EUR | 11.609 | 31.445 | 42.578 | 103.041 | 90.976 | 44.044 | 165.629 | -48.269 | 62 | 0 |
| Employees | 1 | 3 | 6 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Oralis Medical Concept S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 86 | 50 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 52.641 | 89.002 | 104.381 | 124.134 | 172.343 | 83.694 | 170.845 | 12.342 | 9.440 | 9.388 |
| Inventories | 31.708 | 33.983 | 47.401 | 83.916 | 134.793 | 36.332 | 44.846 | 4.213 | 3.829 | 3.807 |
| Receivables | 9.105 | 9.445 | 21.203 | 11.069 | 9.540 | 21.255 | 3.929 | 4.828 | 4.706 | 4.679 |
| Cash | 11.829 | 45.574 | 35.777 | 29.149 | 28.010 | 26.107 | 122.069 | 3.301 | 906 | 901 |
| Shareholders Funds | 11.654 | 42.980 | 84.830 | 103.093 | 91.027 | 44.094 | 165.678 | 11.197 | 238 | 237 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 41.090 | 46.099 | 19.592 | 21.056 | 81.316 | 39.600 | 5.167 | 1.144 | 9.202 | 9.151 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Oralis Medical Concept S.r.l.